EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Antiangiogenic therapy in the management of brain tumors: a clinical overview.

Authors

Kunnakkat, Saroj; Mathew, Maya; Narayana, Ashwatha

Abstract

Central to the process of brain tumor development is angiogenesis, which involves a host of molecules and receptors. In recent years, antiangiogenic therapies have been developed and tested for their effectiveness against these tumors. Among them are inhibitors against vascular endothelial growth factor and its receptors, as well as inhibitors targeting the platelet-derived growth factor family, integrins, and histone deacetylase. While many have been shown to be effective with limited toxicity, some tumors are able to adopt escape mechanisms. Further research is needed in the development of effective multi-targeted agents to reduce these effects.

Subjects

BRAIN tumor treatment; NEOVASCULARIZATION inhibitors; VASCULAR endothelial growth factors; VASCULAR endothelial growth factor receptors; PLATELET-derived growth factor; INTEGRINS; HISTONE deacetylase

Publication

Cancer Chemotherapy & Pharmacology, 2012, Vol 70, Issue 3, p353

ISSN

0344-5704

Publication type

Academic Journal

DOI

10.1007/s00280-012-1926-7

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved